Sean P. Bohen

Variation in gene expression patterns in follicular lymphoma and the response to rituximab

David Botstein, Olga G. Troyanskaya, Patrick O. Brown, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Lebrikizumab treatment in adults with asthma.

Nicola A Hanania, Zheng Su, Sofia Mosesova, 2011, The New England journal of medicine.

Expression profiles of adult T-cell leukemia–lymphoma and associations with clinical responses to zidovudine and interferon α

Ash A. Alizadeh, I. Lossos, J. Martinez-Climent, 2010, Leukemia & lymphoma.

Hsp90 Mutants Disrupt Glucocorticoid Receptor Ligand Binding and Destabilize Aporeceptor Complexes *

S. Bohen, Sean P. Bohen, 1995, The Journal of Biological Chemistry.

Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids.

S. Mosesova, P. Korenblat, J. Matthews, 2013, The Journal of allergy and clinical immunology.

DNA Damage Response – An Emerging Target for Groundbreaking Cancer Therapies

M. O’Connor, S. Bohen, Sean P. Bohen, 2018 .

Genetic and Biochemical Analysis of p23 and Ansamycin Antibiotics in the Function of Hsp90-Dependent Signaling Proteins

S. Bohen, Sean P. Bohen, 1998, Molecular and Cellular Biology.

Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90.

L. Neckers, J. Toretsky, M. Blagosklonny, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Isolation of Hsp90 mutants by screening for decreased steroid receptor function.

K. Yamamoto, S. Bohen, Sean P. Bohen, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Hold 'em and fold 'em: chaperones and signal transduction.

K. Yamamoto, S. Bohen, Sean P. Bohen, 1995, Science.

LEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones.

K. Yamamoto, K. Yamamoto, S. Bohen, 1995, Proceedings of the National Academy of Sciences of the United States of America.